CMS Rule Cuts Medicaid Coverage of Trans Youth Care
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- CMS finalized a rule barring federal Medicaid (under 18) and CHIP (under 19) funds from covering gender-affirming medication and surgery, set to take effect Oct. 13, while leaving mental health coverage and state-funded care untouched.
- HHS released a separate report Thursday on diagnostic coding practices and referred hundreds of healthcare groups to the Justice Department for investigation, escalating pressure beyond the coverage rule itself.
- CMS followed standard regulatory procedure and fielded nearly 35,000 public comments, which legal experts say positions the rule to better withstand challenges than the executive order and DOJ subpoenas already blocked in court.
- Massachusetts Attorney General Andrea Campbell's office confirmed plans to sue, while lawyers call the legal basis a "gray area" — CMS cites a 1976 sterilization regulation but lacks any Congressional directive to unilaterally revoke a covered benefit.
- KFF estimates roughly 130,000 transgender youth on Medicaid or CHIP live in states where gender-affirming care remains legal and could lose federal funding for treatment.
- The final rule includes a six-month "tapering period" continuing hormone coverage until April 2027, prompting questions from lawyers about whether the agency is trying to end treatment outright rather than just restrict federal dollars.
- A companion proposed rule could restrict Medicaid participation for hospitals that provide gender-affirming care to minors — a move experts say is more legally vulnerable and is being held back to test the waters with this coverage ban first.
Why it matters: If this rule survives court review, an estimated 130,000 trans youth in states where care remains legal could lose federal coverage, and CMS would assert unprecedented authority to unilaterally drop a covered Medicaid benefit without Congressional action. Its survival could also embolden a more sweeping companion rule targeting hospitals still providing gender-affirming care.
Ask SkimNews
